Singapore: As per a recent report published in the Shanghai Securities News, China's leading price regulator will crack ...
China has cracked down on high prices and corruption in the healthcare sector. Nonetheless, the revenue growth of publ...
Singapore: China vaccine firm, Sinovac Biotech, is selected by Beijing Health Bureau as the sole supplier of inactivated...
Singapore: Logistics firm, Marken, is awarded the Best Life Science Logistics Service Provider at BioPharma Asia Industr...
Singapore: China Kanghui Holdings, a leading domestic developer, manufacturer and marketer of orthopedic implants in Chi...
Singapore: 3SBio, China based biotechnology company, has signed license agreement with JenKem Technology to develop, man...
Singapore: Biostar Pharmaceuticals, a China-based manufacturer and marketer of pharmaceutical and health supplement prod...
Singapore: Dehaier Medical Systems, an emerging leader in the development, assembly, marketing and sale of medical devic...
‎Singapore: Sinovac Biotech, a leading provider of biopharmaceutical products in China, has touched sales of $10.1...
China-based start-up company Shanghai BravoBio is dedicated to developing new types of human vaccines to fight against e...
In the 1980s, a lot of people in China suffered due to the outbreak of hepatitis A. There was no effective method to con...
Singapore: A recent analysis conducted jointly by McKinsey & Co and the China Pharmaceutical Association, the countr...
Singapore: GlaxoSmithKline, the British drug maker that is facing accusations of bribery and corruption in China seems t...
Singapore: Amerigen Pharmaceuticals's Chinese subsidiary, Suzhou Amerigen Pharmaceuticals, entered into a marketing and ...
Singapore: The newly revised policy on Good Supply Practice for Pharma Products (GSP) was recently adopted at the execu...
Singapore: Non-small cell lung cancer (NSCLC) therapeutics market value in the Asia-Pacific (APAC) region, Australia, Ch...
Singapore: Australian infectious disease therapy and vaccine development company, BioDiem, has received an early annual ...
Singapore: Western Europe, the US and Japan will continue to account for almost 60 percent of the total market, accordin...
Singapore: Addressing the global media for the first time after allegations were leveled out against Britain's largest d...
Biotechnology has helped Jiangxi Copper, China's largest producer of copper, remove tons of copper from waste water at i...
Singapore: China plans to boost its biotechnology industry and hopes to keep the average annual rate of growth of the in...
Singapore: Johnson & Johnson is the next multinational company after GSK and many others to fall into China's corrup...
Mr Malcolm Burgess relocated to Hong Kong in 2011 to take up the role of executive vice president of ICON with special r...
Singapore: Teva Pharma CEO, Mr Jeremy Levin, has revealed that Brazil and China are the next target markets for the firm...
Singapore: Sihuan Pharmaceutical's pinoxacin hydrochloride, a Category 1.1 new drug developed by the company's innovativ...
